“Inside the Body’s Battle: Understanding Autoimmune Diseases- Causes and Risks
Autoimmune diseases are a group of complex and diverse disorders that arise when the body’s immune system, which is designed to protect against foreign invaders like bacteria and viruses, mistakenly attacks its healthy cells and tissues [1].
What does a healthy immune system do?
The immune system is a highly sophisticated defense mechanism that includes a network of specialized cells, tissues, and molecules working together to identify and neutralize potential threats. It can distinguish between “self” (the body’s own cells and tissues) and “non-self” (foreign invaders) through a process called immune tolerance. Immune tolerance ensures that the immune system does not attack the body’s own cells, preventing autoimmune reactions under normal circumstances [2].
When the problem occurs….
In autoimmune diseases, however, this self-tolerance mechanism is disrupted, and the immune system becomes hyperactive, perceiving some of the body’s components as foreign invaders. As a result, immune cells, particularly T-cells and B-cells, produce autoantibodies and inflammatory cytokines that attack and damage healthy tissues, leading to the characteristic symptoms and complications associated with each autoimmune condition [3].
Why it happens…
The exact causes of autoimmune diseases are not fully understood, but they are believed to result from a complex interplay of genetic, environmental, and hormonal factors [4]. Certain individuals may have a genetic predisposition to developing autoimmune diseases, making them more susceptible to triggers from environmental factors such as infections, stress, diet, and exposure to certain chemicals or drugs [3].
Autoimmune diseases can affect people of all ages, genders, and ethnic backgrounds, and they can range from mild to severe, chronic, and even life-threatening. While there is no cure for most autoimmune diseases, medical advancements have led to significant improvements in diagnosis, treatment, and management of these conditions, aiming to control symptoms, prevent complications, and enhance the quality of life for individuals living with autoimmune diseases.
Mechanisms of Autoimmunity
The mechanism of autoimmunity involves several key steps:
Genetic Predisposition: Autoimmune diseases often have a genetic component, meaning certain genes may increase a person’s susceptibility to developing an autoimmune condition. These genetic factors can influence the immune system’s regulation and response to self-antigens.
Triggering Event: While genetics play a role, environmental factors are also crucial in triggering autoimmune responses. These environmental triggers can include infections, certain drugs, hormonal changes, and exposure to chemicals or toxins. These events may cause changes in the body that lead to the activation of the immune system against self-antigens.
Loss of Tolerance: Normally, the immune system maintains tolerance to the body’s own cells and tissues, preventing autoimmunity. Tolerance refers to the ability of the immune system to recognize and not attack “self” antigens. In autoimmune diseases, this tolerance is disrupted, and immune cells start recognizing self-antigens as foreign.
Antigen Presentation: Antigens are molecules that trigger an immune response. In autoimmunity, self-antigens are presented to immune cells, such as T cells and B cells, by specialized cells called antigen-presenting cells (APCs). These self-antigens may come from damaged or stressed cells that release previously hidden antigens.
T Cell Activation: T cells are a type of immune cell that plays a central role in autoimmune responses. In autoimmunity, self-reactive T cells are activated by the presentation of self-antigens. Once activated, these T cells become sensitized to self-antigens and start attacking the body’s own tissues.
B Cell Activation and Autoantibody Production: B cells are another type of immune cell that can produce antibodies. In autoimmunity, self-reactive B cells are also activated, and they start producing autoantibodies against self-antigens. These autoantibodies can directly attack tissues or form immune complexes that contribute to tissue damage and inflammation.
Tissue Damage and Inflammation: The attack on self-tissues by activated T cells and autoantibodies leads to tissue damage and inflammation in the affected organs. The extent and specific manifestations of damage depend on the particular autoimmune disease and the organs involved.
Autoimmune diseases can affect virtually any part of the body, and there are more than 80 known autoimmune disorders [5].
Normal Immune Response vs. Autoimmune Response
The key differences between a normal immune response and an autoimmune response lie in their targets and the way the immune system functions. Let’s compare the two:
Normal Immune Response:
Pathogen Specificity: In a normal immune response, the immune system recognizes and responds to specific foreign invaders, such as bacteria, viruses, fungi, or parasites. It targets these pathogens to eliminate them from the body.
Self-Tolerance: A healthy immune system is capable of distinguishing between the body’s own cells and foreign substances. It maintains self-tolerance, meaning it does not attack the body’s own tissues and organs.
Controlled Inflammation: In response to infection or injury, the immune system triggers inflammation to contain and eliminate pathogens, promote tissue repair, and support healing. Once the threat is eliminated, inflammation resolves.
Activation and Regulation: The immune response is tightly controlled by a complex network of immune cells and molecules. Immune cells like T cells and B cells are activated when needed and regulated to prevent excessive immune reactions.
Autoimmune Response:
Loss of Self-Tolerance: In autoimmunity, the immune system loses its ability to distinguish between self and non-self. As a result, it starts recognizing the body’s own cells and tissues as foreign invaders (antigens).
Autoantibodies and Autoimmunity: Activated immune cells, particularly B cells, produce autoantibodies that target self-antigens. These autoantibodies attack and damage the body’s own tissues, leading to various autoimmune diseases.
Chronic Inflammation: Autoimmune responses often lead to chronic inflammation in the affected organs. This ongoing inflammation can cause tissue damage and disrupt normal organ function.
Escalating Cycle: In many autoimmune diseases, the damage caused by the immune response can release more self-antigens, perpetuating the autoimmune cycle and leading to further immune activation and tissue destruction.
Specificity Varies: Different autoimmune diseases target different organs or tissues. For example, in rheumatoid arthritis, joints are primarily affected, while in multiple sclerosis, the central nervous system is targeted.
Genetic and Environmental Factors: Autoimmune diseases often have a genetic predisposition, but environmental triggers, such as infections, stress, and certain medications, can play a role in initiating or exacerbating autoimmune responses.
Treatment Challenges: Treating autoimmune diseases can be complex, as the goal is to suppress the overactive immune response without compromising the immune system’s ability to protect against infections.
Risk Factors Contributing to Autoimmune Disorders
1. Genetic Predisposition
Genetic factors play a significant role in the development of autoimmunity. Although the exact mechanisms are complex and not fully understood, research has identified certain genetic components that contribute to an individual’s susceptibility to autoimmune diseases. Here are some key genetic factors behind autoimmunity:
Human Leukocyte Antigen (HLA) Genes: HLA genes encode proteins that play a crucial role in the immune system’s ability to recognize and distinguish between self and non-self antigens. These proteins are found on the surface of cells and are responsible for presenting antigens to T cells, which are central to the immune response. Specific variations in HLA genes have been strongly associated with various autoimmune diseases. For example, HLA-DRB1 alleles are linked to increased susceptibility to rheumatoid arthritis, while HLA-DQ2 and HLA-DQ8 are strongly associated with celiac disease [6].
Cytokine Gene Polymorphisms: Cytokines are small proteins involved in cell signaling and immune responses. Variations in genes that encode certain cytokines have been linked to an increased risk of developing autoimmune diseases. For instance, specific polymorphisms in the IL-23R gene have been associated with inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis [7].
Autoimmune Regulator (AIRE) Gene: The AIRE gene is involved in the development of immune tolerance by regulating the expression of self-antigens in the thymus. Mutations in this gene can lead to a rare autoimmune disorder called Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED), which results in the immune system attacking various endocrine organs [8].
Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22) Gene: Variations in the PTPN22 gene have been associated with several autoimmune diseases, including rheumatoid arthritis, type 1 diabetes, and systemic lupus erythematosus. This gene is involved in the regulation of T cell activation and function [1, 9].
Interferon-Inducible Genes: Interferons are signaling proteins that play a critical role in the body’s response to infections and immune regulation. Certain genetic variants in interferon-inducible genes have been linked to an increased risk of autoimmune diseases, such as systemic lupus erythematosus [10].
2. Environmental Triggers
Environmental factors play a significant role in the development and exacerbation of autoimmune diseases. These factors can trigger or influence the immune system’s response, leading to the breakdown of self-tolerance and the initiation of autoimmunity. Some common environmental factors associated with autoimmune diseases include:
Infections: Certain infections have been linked to the onset or worsening of autoimmune diseases. For example, viral infections, such as Epstein-Barr virus (EBV), have been associated with an increased risk of developing multiple sclerosis (MS) and systemic lupus erythematosus (SLE). Infections can trigger an immune response that cross-reacts with self-antigens, leading to autoimmune reactions [11].
Hormonal Changes: Autoimmune diseases are more prevalent in women, suggesting a role for hormonal factors. Hormonal changes, such as those occurring during puberty, pregnancy, and menopause, may influence the immune system’s regulation and contribute to the development of certain autoimmune conditions [12].
Vitamin D Deficiency: Vitamin D is important for immune system regulation and function. Low levels of vitamin D have been associated with an increased risk of autoimmune diseases, including type 1 diabetes, multiple sclerosis, and rheumatoid arthritis.
Smoking: Cigarette smoking has been linked to an increased risk of several autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. Smoking can promote inflammation and alter the immune system’s response, contributing to autoimmunity.
Diet: Certain dietary factors have been implicated in the development and management of autoimmune diseases. For example, gluten intake is a key trigger for celiac disease, an autoimmune condition affecting the gut in genetically susceptible individuals. Additionally, some autoimmune diseases may benefit from anti-inflammatory diets rich in fruits, vegetables, and omega-3 fatty acids.
Stress: Chronic stress can impact the immune system and increase susceptibility to autoimmune diseases. Stress hormones can alter immune responses, potentially leading to autoimmunity in susceptible individuals.
Medications and Chemical Exposures: Certain medications and chemical exposures have been associated with the development of autoimmune diseases. For instance, certain drugs used to treat hypertension and heart conditions have been linked to drug-induced lupus, a form of lupus triggered by medications.
Gut Microbiome: Emerging research suggests that the gut microbiome, the community of microbes living in the digestive tract, may influence the development of autoimmune diseases. An imbalance in gut bacteria (dysbiosis) may contribute to immune dysfunction and autoimmunity
REFERENCES
1. Abbas, Abul K., Andrew H. Lichtman, and Shiv Pillai. Basic immunology e-book: functions and disorders of the immune system. Elsevier Health Sciences, 2019.
2. Langman, R. (2014). The immune system. Elsevier.
3. Shoenfeld, Y., Meroni, P. L., & Gershwin, M. E. (Eds.). (2013). Autoantibodies. Newnes.
4. Touil, H., Mounts, K., & De Jager, P. L. (2023). Differential impact of environmental factors on systemic and localized autoimmunity. Frontiers in Immunology, 14, 1147447.
5. Bieber, K., Hundt, J. E., Yu, X., Ehlers, M., Petersen, F., Karsten, C. M., … & Ludwig, R. J. (2023). Autoimmune pre-disease. Autoimmunity reviews, 22(2), 103236.
6. Mosaad, Y. M. (2015). Clinical role of human leukocyte antigen in health and disease. Scandinavian journal of immunology, 82(4), 283–306.
7. Cookson, S., Constantini, P. K., Clare, M., Underhill, J. A., Bernal, W., Czaja, A. J., & Donaldson, P. T. (1999). Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology, 30(4), 851–856.
8. Wolff, A. S., & Oftedal, B. E. (2019). Aire mutations and autoimmune diseases. Thymus Transcriptome and Cell Biology, 191–214.
9. Huraib, G. B., Al Harthi, F., Arfin, M., & Al-Asmari, A. (2020). The Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22) Gene Polymorphism and Susceptibility to Autoimmune Diseases. In The Recent Topics in Genetic Polymorphisms. London, UK: IntechOpen.
10. Karagianni, P., & Tzioufas, A. G. (2019). Epigenetic perspectives on systemic autoimmune disease. Journal of Autoimmunity, 104, 102315.
11. Johnson, D., & Jiang, W. (2023). Infectious diseases, autoantibodies, and autoimmunity. Journal of Autoimmunity, 137, 102962.
12. Desai, M. K., & Brinton, R. D. (2019). Autoimmune disease in women: endocrine transition and risk across the lifespan. Frontiers in endocrinology, 10, 265.
